Patient Engagement Solutions Market Size, Share, Growth, Trends, Company Analysis, Regional Insights and Forecast 2020 - 2027

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Patient Engagement Solutions Market, By Delivery Type

7.1.  Patient Engagement Solutions Market, By Delivery Type, 2020-2030

7.1.1.    Web-based/Cloud-based

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    On-premise

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Patient Engagement Solutions Market, By Component Type

8.1.  Patient Engagement Solutions Market, By Component Type, 2020-2030

8.1.1.    Software

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Services

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Hardware

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Patient Engagement Solutions Market, By End-use Type

9.1.  Patient Engagement Solutions Market, By End-use Type, 2020-2030

9.1.1.    Payers

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Providers

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Individual Users

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Patient Engagement Solutions Market, By Application Type

10.1.        Patient Engagement Solutions Market, By Application Type, 2020-2030

10.1.1.  Social Management

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Health Management

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Home Healthcare Management

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Financial Health Management

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Patient Engagement Solutions Market, By Therapeutic Area Type

11.1.        Patient Engagement Solutions Market, by Therapeutic Area, 2020-2030

11.1.1.  Chronic diseases

11.1.1.1.      Market Revenue and Forecast (2016-2030)

11.1.2.  Fitness

11.1.2.1.      Market Revenue and Forecast (2016-2030)

11.1.3.  Women's Health

11.1.3.1.      Market Revenue and Forecast (2016-2030)

11.1.4.  Mental Health

11.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 12.      Global Patient Engagement Solutions  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, By Delivery Type (2016-2030)

12.1.2.  Market Revenue and Forecast, By Component (2016-2030)

12.1.3.  Market Revenue and Forecast, By End-use (2016-2030)

12.1.4.  Market Revenue and Forecast, By Application (2016-2030)

12.1.5.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.1.6.2.      Market Revenue and Forecast, By Component (2016-2030)

12.1.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.1.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.1.7.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.1.8.  Rest of North America

12.1.8.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.1.8.2.      Market Revenue and Forecast, By Component (2016-2030)

12.1.8.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.1.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.1.8.5.      Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, By Delivery Type (2016-2030)

12.2.2.  Market Revenue and Forecast, By Component (2016-2030)

12.2.3.  Market Revenue and Forecast, By End-use (2016-2030)

12.2.4.  Market Revenue and Forecast, By Application (2016-2030)

12.2.5.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.2.6.2.      Market Revenue and Forecast, By Component (2016-2030)

12.2.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.2.7.  Market Revenue and Forecast, By Application (2016-2030)

12.2.8.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.2.9.  Germany

12.2.9.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.2.9.2.      Market Revenue and Forecast, By Component (2016-2030)

12.2.9.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.2.10.               Market Revenue and Forecast, By Application (2016-2030)

12.2.11.               Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.2.12.               France

12.2.12.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.2.12.2.   Market Revenue and Forecast, By Component (2016-2030)

12.2.12.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.2.12.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.13.               Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.2.14.               Rest of Europe

12.2.14.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.2.14.2.   Market Revenue and Forecast, By Component (2016-2030)

12.2.14.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.2.14.4.   Market Revenue and Forecast, By Application (2016-2030)

12.2.15.               Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, By Delivery Type (2016-2030)

12.3.2.  Market Revenue and Forecast, By Component (2016-2030)

12.3.3.  Market Revenue and Forecast, By End-use (2016-2030)

12.3.4.  Market Revenue and Forecast, By Application (2016-2030)

12.3.5.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.3.6.2.      Market Revenue and Forecast, By Component (2016-2030)

12.3.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.3.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.3.7.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.3.8.  China

12.3.8.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.3.8.2.      Market Revenue and Forecast, By Component (2016-2030)

12.3.8.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.3.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.3.9.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.3.10.               Japan

12.3.10.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.3.10.2.   Market Revenue and Forecast, By Component (2016-2030)

12.3.10.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.3.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.10.5.   Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.3.11.               Rest of APAC

12.3.11.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.3.11.2.   Market Revenue and Forecast, By Component (2016-2030)

12.3.11.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.3.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.3.11.5.   Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, By Delivery Type (2016-2030)

12.4.2.  Market Revenue and Forecast, By Component (2016-2030)

12.4.3.  Market Revenue and Forecast, By End-use (2016-2030)

12.4.4.  Market Revenue and Forecast, By Application (2016-2030)

12.4.5.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.4.6.2.      Market Revenue and Forecast, By Component (2016-2030)

12.4.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.4.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.4.7.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.4.8.  North Africa

12.4.8.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.4.8.2.      Market Revenue and Forecast, By Component (2016-2030)

12.4.8.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.4.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.4.9.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.4.10.               South Africa

12.4.10.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.4.10.2.   Market Revenue and Forecast, By Component (2016-2030)

12.4.10.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.10.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.10.5.   Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.4.11.               Rest of MEA

12.4.11.1.   Market Revenue and Forecast, By Delivery Type (2016-2030)

12.4.11.2.   Market Revenue and Forecast, By Component (2016-2030)

12.4.11.3.   Market Revenue and Forecast, By End-use (2016-2030)

12.4.11.4.   Market Revenue and Forecast, By Application (2016-2030)

12.4.11.5.   Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, By Delivery Type (2016-2030)

12.5.2.  Market Revenue and Forecast, By Component (2016-2030)

12.5.3.  Market Revenue and Forecast, By End-use (2016-2030)

12.5.4.  Market Revenue and Forecast, By Application (2016-2030)

12.5.5.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.5.6.2.      Market Revenue and Forecast, By Component (2016-2030)

12.5.6.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.5.6.4.      Market Revenue and Forecast, By Application (2016-2030)

12.5.7.  Market Revenue and Forecast, by Therapeutic Area (2016-2030)

12.5.8.  Rest of LATAM

12.5.8.1.      Market Revenue and Forecast, By Delivery Type (2016-2030)

12.5.8.2.      Market Revenue and Forecast, By Component (2016-2030)

12.5.8.3.      Market Revenue and Forecast, By End-use (2016-2030)

12.5.8.4.      Market Revenue and Forecast, By Application (2016-2030)

12.5.8.5.      Market Revenue and Forecast, by Therapeutic Area (2016-2030)

Chapter 13.  Company Profiles

13.1.              Allscripts Healthcare Solutions

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              McKesson Corporation

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Orion Health Ltd

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Cerner Corporation

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              Phytel Inc.

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Medecision Inc

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              GetWellNetwork Inc

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              YourCareUniverse Inc.

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Lincor Solutions Ltd.

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Athenahealth, Inc

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

Glossary of Terms